517 related articles for article (PubMed ID: 31196160)
1. Safety and efficacy of ex vivo expanded CD34
Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo Expansion of CD34
Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
[TBL] [Abstract][Full Text] [Related]
3. Ex-vivo expansion of nonhuman primate CD34
Shen B; Zhang Y; Dai W; Ma Y; Jiang Y
Stem Cell Res Ther; 2016 Oct; 7(1):152. PubMed ID: 27765075
[TBL] [Abstract][Full Text] [Related]
4. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
5. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.
Galy AH; Cen D; Travis M; Chen S; Chen BP
Blood; 1995 May; 85(10):2770-8. PubMed ID: 7537981
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
7. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
[TBL] [Abstract][Full Text] [Related]
8. Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells.
Chute JP; Muramoto GG; Fung J; Oxford C
Blood; 2005 Jan; 105(2):576-83. PubMed ID: 15345596
[TBL] [Abstract][Full Text] [Related]
9. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
11. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
Kadekar D; Kale V; Limaye L
Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
[TBL] [Abstract][Full Text] [Related]
12. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
[TBL] [Abstract][Full Text] [Related]
13. A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation.
Wang L; Guan X; Wang H; Shen B; Zhang Y; Ren Z; Ma Y; Ding X; Jiang Y
Stem Cell Res Ther; 2017 Jul; 8(1):169. PubMed ID: 28720126
[TBL] [Abstract][Full Text] [Related]
14. Coinhibition of activated p38 MAPKα and mTORC1 potentiates stemness maintenance of HSCs from SR1-expanded human cord blood CD34
Li X; Ma X; Chen Y; Peng D; Wang H; Chen S; Xiao Y; Li L; Zhou H; Cheng F; Gao Y; Chang J; Cheng T; Liu L
Stem Cells Transl Med; 2020 Dec; 9(12):1604-1616. PubMed ID: 32602209
[TBL] [Abstract][Full Text] [Related]
15. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
16. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
Du Z; Wang Z; Zhang W; Cai H; Tan WS
Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
[TBL] [Abstract][Full Text] [Related]
18. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells.
Rosler ES; Brandt JE; Chute J; Hoffman R
Blood; 2000 Nov; 96(10):3414-21. PubMed ID: 11071636
[TBL] [Abstract][Full Text] [Related]
19. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M
Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
